Rizvi, S. N. F., Visser, O. J., Vosjan, M. J. W. D., van Lingen, A., Hoekstra, O. S., Zijlstra, J. M., . . . Lubberink, M. (2012). Biodistribution, radiation dosimetry and scouting of (90)Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using (89)Zr-ibritumomab tiuxetan and PET. Springer-Verlag.
Style de citation ChicagoRizvi, Saiyada N. F., Otto J. Visser, Maria J. W. D. Vosjan, Arthur van Lingen, Otto S. Hoekstra, Josée M. Zijlstra, Peter C. Huijgens, Guus A. M. S. van Dongen, et Mark Lubberink. Biodistribution, Radiation Dosimetry and Scouting of (90)Y-ibritumomab Tiuxetan Therapy in Patients With Relapsed B-cell Non-Hodgkin’s Lymphoma Using (89)Zr-ibritumomab Tiuxetan and PET. Springer-Verlag, 2012.
Style de citation MLARizvi, Saiyada N. F., et al. Biodistribution, Radiation Dosimetry and Scouting of (90)Y-ibritumomab Tiuxetan Therapy in Patients With Relapsed B-cell Non-Hodgkin’s Lymphoma Using (89)Zr-ibritumomab Tiuxetan and PET. Springer-Verlag, 2012.